MA11.119, Implantable Pulmonary Artery Pressure Sensors for Heart Failure Management
Summary
Independence Blue Cross reissued MA11.119 with no substantive changes to its coverage policy for implantable pulmonary artery pressure sensors (PAPS) for heart failure management. The policy maintains Coverage with Evidence Development (CED) as the only covered pathway, requiring enrollment in approved CMS clinical studies and strict eligibility criteria. This is an administrative reissue as part of the annual review process; no billing workflow changes are required.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.